K. Trusinskis

发表

Bioresorbable Scaffold Use in Coronary Chronic Total Occlusions: A Long-Term, Single-Center Follow-Up Study

I. Narbute, I. Kumsārs, Aigars Lismanis, 2024, Medicina.

Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs

I. Tkáč, K. Lalić, J. Gumprecht, 2019, Cardiovascular Diabetology.

Carotid artery stenting outcomes in high-risk patients receiving best medical therapy: Results from a single high-volume interventional cardiology practice

A. Erglis, I. Kumsārs, K. Trušinskis, 2016 .

Homocysteine, Β Vitamins and Immune Activation in Coronary Heart Disease

D. Fuchs, U. Kalnins, A. Erglis, 2003 .

Coronary Artery Disease in Women: Lessons Learned from Single-Center SPECT Registry and Future Directions for INOCA Patients

A. Erglis, I. Mintāle, K. Trušinskis, 2022, Medicina.

Plasma circulating microRNAs in patients with stable coronary artery disease – Impact of different cardiovascular risk profiles and glomerular filtration rates

A. Erglis, I. Konrāde, Sanda Jēgere, 2021, Journal of clinical and translational research.

Culprit versus Complete Revascularization during the Initial Intervention in Patients with Acute Coronary Syndrome Using a Virtual Treatment Planning Tool: Results of a Single-Center Pilot Study

K. Trušinskis, A. Lejnieks, N. Pontaga, 2023, Medicina.

Usefulness of Neopterin, C-reactive Protein, Homocysteine, Pyridoxal-5-phosphate, and Phospholipid Determination in Coronary Artery Disease

D. Fuchs, U. Kalnins, A. Erglis, 2005 .

Original papers Indexes of inflammation and other secondary risk factors in the progression of coronary artery disease

D. Fuchs, U. Kalnins, A. Erglis, 2004 .

Indexes of inflammation and other secondary risk factors in the progression of coronary artery disease

D. Fuchs, U. Kalnins, A. Erglis, 2004 .